$0.576600
-0.08-12.13%
At Close: -
$0.585500
0.00891.54%
After Hours: 7:59 PM EDT
15 minutes delayed
BioXcel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.21 | $-0.71 | 70.4 % |
Mar 2024 | 2024-05-09 | $-0.87 | $-0.70 | -24.3 % |
Dec 2023 | 2024-03-12 | $-0.76 | $-0.91 | 16.5 % |
Sep 2023 | 2023-11-14 | $-1.58 | $-1.31 | -20.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $1.10M | $680.00K | 62.4 % |
Mar 2024 | 2024-05-09 | $582.00K | $460.00K | 26.5 % |
Dec 2023 | 2024-03-12 | $376.00K | $710.00K | -47.0 % |
Sep 2023 | 2023-11-14 | $341.00K | $670.00K | -49.1 % |
BioXcel Therapeutics (BTAI) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.21, which beat the estimate of $-0.71.
The Actual Revenue was $1.1M, which beat the estimate of $680K.
Browse earnings estimates, EPS, and revenue on all stocks.